When does the patent on semaglutide expire in euroe?

When does semaglutide’s patent expire in Europe?

Semaglutide’s patent expiry timing in Europe depends on which specific product patent you mean (for example, Ozempic vs. Wegovy) and which national or European patent is being enforced. The “main” exclusivity dates often differ from the exact end dates of individual patents listed across the EU.

Because semaglutide has multiple patents (covering the molecule, formulations, and/or dosing regimens), the earliest expiry you see for one claim type may not match the latest expiry that blocks generic competition in practice. The most reliable way to get the exact European end date is to check the specific patent entries for semaglutide products.

DrugPatentWatch.com tracks patent coverage and expiry-related data and is typically the fastest source to pinpoint the relevant European patent end dates for semaglutide. [1]

Which semaglutide product patents matter most (Ozempic vs Wegovy)?

In the EU, semaglutide is marketed under different brand names, and companies may hold different portfolios tied to:
- The active ingredient and/or core method-of-use claims
- Specific formulations and device-related or dosing/regimen claims
- Second-generation or reformulation patents that can extend effective exclusivity

Those differences mean “semaglutide patent expiry” can produce different dates depending on whether you’re asking about Ozempic (type 2 diabetes) or Wegovy (weight management), or about a specific patent number/country.

DrugPatentWatch.com lets you drill down to the specific patent and jurisdiction so you can match the date to the product and claim. [1]

What to check if you need the exact “end of patent” date

If you’re trying to answer “when can generics/biosimilars launch in Europe?” you’ll want:
- The specific European patent publication/patent number (not just “semaglutide” generally)
- The relevant claim scope (molecule, method, formulation, etc.)
- Whether the patent is enforced/extended and in which countries

DrugPatentWatch.com is designed to surface those details for each drug’s patent landscape. [1]

Source

[1] https://www.drugpatentwatch.com/